Diabetes News and Research

Latest Diabetes News and Research

Jaeb Center for Health Research awarded $26M grant to accelerate new therapies for type 1 diabetes

The Leona M. and Harry B. Helmsley Charitable Trust, a leader in type 1 diabetes research funding, today announced that the Trust has awarded a three-year, $26 million grant to the Jaeb Center for Health Research. The grant is for the development of a type 1 diabetes exchange that includes a data repository, a biobank and an interactive website with mobile capability.

16 Sep 2010

Study finds aerobic exercise improves chronic insomnia

The millions of middle-aged and older adults who suffer from insomnia have a new drug-free prescription for a more restful night's sleep. Regular aerobic exercise improves the quality of sleep, mood and vitality, according to a small but significant new study from Northwestern Medicine.

16 Sep 2010

ABCB4 gene causes bad cholesterol to accumulate in blood: Research

Scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio have found a gene that causes high levels of bad cholesterol to accumulate in the blood as a result of a high-cholesterol diet.

16 Sep 2010

Bruner to encourage FDA advisory committee to consider effectiveness of obesity drug Lorcaserin

On September 16, Denise Bruner, MD, FASBP will speak in favor of FDA approval for the new obesity drug Lorcaserin, during the open public hearing hour at the Endocrinologic and Metabolic Drug Advisory Committee meeting.

15 Sep 2010

Scientia Advisors reviews growth in POC market

Rapid medical tests that can be analyzed in close proximity to patients in professional settings comprise the fastest growing segment of the global $37.5B in-vitro diagnostics industry, according to a new global review of the point-of-care (POC) diagnostics industry.

15 Sep 2010

A.C.T.S. of F.A.I.T.H. calls for partnerships to address childhood obesity

Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.

15 Sep 2010

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

The American Pain Foundation reports that despite the fact that the majority of the U.S. population looks healthy, statistics tell a different story: Approximately 1 in 3 Americans suffer from chronic pain. This chronic pain could be related to an illness like cancer or rheumatoid arthritis, or a condition such as arthritis, migraine headaches, fibromyalgia or back pain from a car accident.

15 Sep 2010

HHS awards $31 million as part of 'Communities Putting Prevention to Work' program

The U.S. Department of Health and Human Services (HHS) today announced $31 million for awards to ten communities in eight states and one award to a state health department to support public health efforts to reduce obesity and smoking, increase physical activity and improve nutrition.

15 Sep 2010

MRI brain scans can accurately predict young person's age

Using MRI technology and mathematical analysis, researchers at Oregon Health & Science University and Washington University in St. Louis are now able to accurately predict a young person's age simply by studying their brain scans. The research, which will likely have several clinical applications, including assessment and diagnosis, is published in the current edition of the journal Science.

15 Sep 2010

Oramed Pharmaceuticals announces clinical trial results of ORMD-0801 capsule in Type I diabetics

Oramed Pharmaceuticals Inc. announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.

15 Sep 2010

Danny Davis to discuss diabetes, obesity rates in U.S. at UIC Midwest Conference

U.S. Rep. Danny Davis (D-Chicago) will give opening remarks when the Institute of Medicine of the National Academies convenes a regional meeting Sept. 21 at the University of Illinois at Chicago to discuss the rapidly rising rates of diabetes and obesity in the U.S.

15 Sep 2010

Harbor BioSciences releases Apoptone clinical trial data for castration resistant prostate cancer

Harbor BioSciences, Inc. a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released new positive data from its ongoing Phase I/IIa clinical trial with Apoptone(HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

15 Sep 2010

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.

15 Sep 2010

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARC-4558 for the treatment of pain associated with Painful Diabetic Neuropathy (PDN).

15 Sep 2010

UT Southwestern receives $8 million NIH grant to study influence of brain and liver on inflammation

An $8 million grant from the National Institutes of Health will enable UT Southwestern Medical Center to investigate how fat tissue "talks" to the brain and the liver to promote inflammation-related disorders such as diabetes, heart disease and obesity.

15 Sep 2010

Researchers identify risk gene for schizophrenia

An international team of researchers has identified a risk gene for schizophrenia, including a potentially causative mutation, using genome-wide association data-mining techniques and independent replications.

15 Sep 2010

FDA approves Krystexxa drug to treat gout

The U.S. Food and Drug Administration approved Krystexxa (pegloticase) to treat the painful condition known as gout in adults who do not respond to or who cannot tolerate conventional therapy.

15 Sep 2010

Stroke risk with common pain killers dismissed by manufacturer

An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, “it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day.”

14 Sep 2010

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

14 Sep 2010

World Congress on Arthrosis to take place in Belgium from September 23 to 26, 2010

Over a 1000 experts from the world will participate in the Osteoarthritis Research Society International (OARSI) congress, under the Presidency of the Belgian Professor Yves Henrotin (University of Liège).

14 Sep 2010

Diabetes News and Research

Latest Diabetes News and Research

Jaeb Center for Health Research awarded $26M grant to accelerate new therapies for type 1 diabetes

Study finds aerobic exercise improves chronic insomnia

ABCB4 gene causes bad cholesterol to accumulate in blood: Research

Bruner to encourage FDA advisory committee to consider effectiveness of obesity drug Lorcaserin

Scientia Advisors reviews growth in POC market

A.C.T.S. of F.A.I.T.H. calls for partnerships to address childhood obesity

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

HHS awards $31 million as part of 'Communities Putting Prevention to Work' program

MRI brain scans can accurately predict young person's age

Oramed Pharmaceuticals announces clinical trial results of ORMD-0801 capsule in Type I diabetics

Danny Davis to discuss diabetes, obesity rates in U.S. at UIC Midwest Conference

Harbor BioSciences releases Apoptone clinical trial data for castration resistant prostate cancer

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

UT Southwestern receives $8 million NIH grant to study influence of brain and liver on inflammation

Researchers identify risk gene for schizophrenia

FDA approves Krystexxa drug to treat gout

Stroke risk with common pain killers dismissed by manufacturer

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

World Congress on Arthrosis to take place in Belgium from September 23 to 26, 2010

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in